Crinetics (CRNX) PT Raised to $80 at JMP Securities, 'Paltusotine is Faster, Better, and More Convenient'
Tweet Send to a Friend
(Updated - March 20, 2024 3:46 AM EDT)
JMP Securities analyst Jonathan Wolleben raised the price target on Crinetics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JMP Securities analyst Jonathan Wolleben raised the price target on Crinetics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
